Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Sinovac Biotech Ltd (SVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14780
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥40,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive is a combined inactivated hepatitis A and B vaccine. Sinovac Biotech’s anflu is a split viron influenza vaccine. The company’s panflu is a vaccine against the H5N1 influenza vaccine. Its panflu is a vaccine against the influenza A H1N1 virus. The company conducts research to develop novel vaccines for infectious diseases such as SARS, avian influenza, H1N1 influenza and hand foot and mouth disease, among others. It markets its products in China and abroad. Sinovac Biotech is headquartered in Beijing, China.

Sinovac Biotech Ltd Key Recent Developments

Dec 19,2018: Sinovac comments on Antigua and Barbuda court decision denying 1Globe Capital’s Claim; current board was validly elected at Annual General Meeting
Dec 13,2018: Haidian district people’s court in Beijing issues injunction order restraining Aihua Pan from using business license and corporate seal of Sinovac Bei
Dec 07,2018: Sinovac Commences Legal Proceedings to Nullify Filings B…
Nov 29,2018: Hong Kong high court issues declaratory orders and permanent injunctive relief in favor of Sinovac’s Biotech Senior management

This comprehensive SWOT profile of Sinovac Biotech Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sinovac Biotech Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Sinovac Biotech Ltd – Key Information
Sinovac Biotech Ltd – Overview
Sinovac Biotech Ltd – Key Employees
Sinovac Biotech Ltd – Key Employee Biographies
Sinovac Biotech Ltd – Key Operational Heads
Sinovac Biotech Ltd – Major Products and Services
Sinovac Biotech Ltd – History
Sinovac Biotech Ltd – Company Statement
Sinovac Biotech Ltd – Locations And Subsidiaries
Sinovac Biotech Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Sinovac Biotech Ltd – Business Description
Sinovac Biotech Ltd – Corporate Strategy
Sinovac Biotech Ltd – SWOT Analysis
SWOT Analysis – Overview
Sinovac Biotech Ltd – Strengths
Sinovac Biotech Ltd – Weaknesses
Sinovac Biotech Ltd – Opportunities
Sinovac Biotech Ltd – Threats
Sinovac Biotech Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Sinovac Biotech Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Sinovac Biotech Ltd, Key Information
Sinovac Biotech Ltd, Key Ratios
Sinovac Biotech Ltd, Share Data
Sinovac Biotech Ltd, Major Products and Services
Sinovac Biotech Ltd, History
Sinovac Biotech Ltd, Key Employees
Sinovac Biotech Ltd, Key Employee Biographies
Sinovac Biotech Ltd, Key Operational Heads
Sinovac Biotech Ltd, Other Locations
Sinovac Biotech Ltd, Subsidiaries
Sinovac Biotech Ltd, Key Manufacturing facilities
Sinovac Biotech Ltd, Key Competitors
Sinovac Biotech Ltd, SWOT Analysis
Sinovac Biotech Ltd, Ratios based on current share price
Sinovac Biotech Ltd, Annual Ratios
Sinovac Biotech Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Sinovac Biotech Ltd, Performance Chart
Sinovac Biotech Ltd, Ratio Charts

★海外企業調査レポート[Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baron Oil Plc (BOIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kurita Water Industries Ltd:企業の戦略・SWOT・財務情報
    Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • Power Assets Holdings Limited:企業の戦略・SWOT・財務分析
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Neovasc Inc (NVCN):医療機器:M&Aディール及び事業提携情報
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Nitori Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Vinacomin – Coc Sau Coal:企業の戦略・SWOT・財務分析
    Vinacomin - Coc Sau Coal - Strategy, SWOT and Corporate Finance Report Summary Vinacomin - Coc Sau Coal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Infratil Ltd (IFT):企業の財務・戦略的SWOT分析
    Infratil Ltd (IFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ImmunoGen, Inc.:企業のM&A・事業提携・投資動向
    ImmunoGen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ImmunoGen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Cadence Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. Its product allows users to regain the ability and endurance to stand, walk and return …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆